MedPath

Electrosclerotherapy as a novel treatment option for capillary malformations: a pilot study

Phase 2
Completed
Conditions
Capillary malformations
port-wine stains
10005330
Registration Number
NL-OMON45598
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

- Patients with *1 completely or partially hypertrophic capillary malformation not exclusively located in the skin of the face, the skin overlying joints or in mucosal tissue
- Age * 18 years
- Fitzpatrick skin type 1-3 without evident sun tan

Exclusion Criteria

- Pregnant or breastfeeding women
- Women with childbearing potential not using contraception
- Patients with chronic renal dysfunction of GFR <50 ml/minute
- Patients with chronic pulmonary dysfuction, active pulmonary infections or previous bleomycin lung toxicity
- Patients with ataxia teleangiectasia
- Patients with previous allergic reactions to bleomycin
- Patients who already received the maximum dose of bleomycin (400 mg or 400000 IU/m2)
- Patients with implanted electrical devices such as pacemakers or ICD's
- Patients with clinically manifested arrhythmia
- Patients with epilepsy
- Patients who are not able to return to the hospital for follow-up visits
- Patients who are likely not able to understand the terms and risks of the study (e.g. cognitive impairment)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The study parameters are (change in) global assessment of color, thickness,<br /><br>nodularity, pliability, surface area and overall improvement by both the<br /><br>blinded patient and a blinded observer using a global assessment score and the<br /><br>POSAS instrument. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Number and type(s) of adverse events.<br /><br>(Change in) objective color measurement using colorimetry.<br /><br>(Change in) perfusion measured using optical imaging.</p><br>
© Copyright 2025. All Rights Reserved by MedPath